Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Bonig, Halvard  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Thiel U, Wawer A, von Luettichau I, Bender H-U, Blaeschke F, Grunewald TGP, Steinborn M, Röper B, Bonig H, Klingebiel T, et al. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Oncotarget. 2016.
C
Kays S-K, Kaufmann KB, Abel T, Brendel C, Bonig H, Grez M, Buchholz CJ, Kneissl S. CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells. Stem Cells Dev. 2014.
Merker M, Salzmann-Manrique E, Katzki V, Huenecke S, Bremm M, Bakhtiar S, Willasch A, Jarisch A, Soerensen J, Schulz A, et al. Clearance of hematological malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions. Biol Blood Marrow Transplant. 2019.
Pfirrmann V, Oelsner S, Rettinger E, Huenecke S, Bonig H, Merker M, Wels WS, Cinatl J, Schubert R, Klingebiel T, et al. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus. Cytotherapy. 2015.
D
Bremm M, Krastel T, Cappel C, Zimmermann O, Pfeffermann L-M, Katzki V, Bonig H, Schäfer R, Rettinger E, Merker M, et al. Depletion of CD45RA T cells: Advantages and disadvantages of different purification methods. J Immunol Methods. 2021:112960.
F
Ortmann CA, Dorsheimer L, Abou-El-Ardat K, Hoffrichter J, Assmus B, Bonig H, Scholz A, Pfeifer H, Martin H, Schmid T, et al. Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous Transplantation. Cell Rep. 2019;27(7):2022-2028.e3.
Steiner M, Schneider L, Yillah J, Gerlach K, Kuvardina ON, Meyer A, Maring A, Bonig H, Seifried E, Zörnig M, et al. FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation. PLoS One. 2019;14(1):e0210515.
I
Jarisch A, Wiercinska E, Huenecke S, Bremm M, Cappel C, Hauler J, Rettinger E, Soerensen J, Hellstern H, Klusmann J-H, et al. Immune responses to SARS-CoV-2 vaccination in young patients with anti-CD19 CAR-T-induced B-cell aplasia. Transplant Cell Ther. 2022.
Kim-Wanner S-Z, Luxembourg B, Schmidt AH, Schäfer R, Möller N, Herbert E, Poppe C, Hümmer C, Bunos M, Seifried E, et al. Introduction of principles of blood management to healthy donor bone marrow harvesting. Vox Sang. 2020.
M
Doberschuetz N, Soerensen J, Bonig H, Willasch A, Rettinger E, Pfirrmann V, Salzmann-Manrique E, Schäfer R, Klingebiel T, Bader P, et al. Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients. Transfusion. 2019.
Danner E, Hoffmann F, Lee S-Y, Cordes F, Orban S, Dauber K, Chudziak D, Spohn G, Wiercinska E, Tast B, et al. Modest and non-essential roles of the endocannabinoid system in immature hematopoiesis of mice. Exp Hematol. 2019.
S
Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen CMathilde, Yeguas A, Vidriales M-B, González M, Saborido JRial, Kraus S, et al. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (AML). Blood. 2021.
Chow KUwe, Luxembourg B, Seifried E, Bonig H. Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals. Radiology. 2015:150887.
U
Jarisch A, Rettinger E, Sörensen J, Klingebiel T, Schäfer R, Seifried E, Bader P, Bonig H. Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients. J Clin Apher. 2020.
V
Schulz M, Karpova D, Spohn G, Damert A, Seifried E, Binder V, Bonig H. Variant rs1801157 in the 3'UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness. PLoS One. 2015;10(3):e0121859.